Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.326
Revised: October 27, 2013
Accepted: November 12, 2013
Published online: January 7, 2014
Processing time: 174 Days and 5.9 Hours
Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome is a rare genetic disorder and has not been described in China. We present a female infant with neonatal intrahepatic cholestasis from a Chinese family with ARC syndrome. All 23 coding exons and flanking introns of the VPS33B gene were amplified and sequenced using peripheral lymphocyte genomic DNA of the patient and her parents. Genetic testing revealed two novel mutations (c.1033delA and c.1567C>T) in the VPS33B gene. The patient is a compound heterozygote and her parents were heterozygous for each of the mutations.
Core tip: In our study, we present a female infant with neonatal intrahepatic cholestasis from a Chinese family, who was eventually diagnosed with arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome by genetic analysis. She will be the first patient with ARC syndrome reported in China. Genetic testing revealed two novel mutations (c.1033delA, p.I345LfsX8 and c.1567C>T, p.R523X) in VPS33B, which is the causative gene. The patient is a compound heterozygote and her parents were heterozygous for each mutation. Our paper will expand the worldwide distribution of ARC syndrome and the mutation spectrum of VPS33B.